Baker Bros. Advisors LP Horizon Therapeutics Public LTD CO Transaction History

Baker Bros. Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $10.5 Million - $15.1 Million	-178,777 Reduced 15.57%	969,727 $60 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $19.8 Million - $29.1 Million	249,662 Added 27.78%	1,148,504 $91.6 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $25.9 Million - $32.9 Million	299,732 Added 50.03%	898,842 $94.6 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $4.52 Million - $5.69 Million	-67,390 Reduced 10.11%	599,110 $43.8 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $25.8 Million - $37.3 Million	466,500 Added 233.25%	666,500 $51.8 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $4.97 Million - $7.71 Million	200,000 New	200,000 $5.92 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.